New invention: New analgesics with adjuvant anticancer properties

Group of inventors from Poland presented at the Brussels Innova Invention Fair 2013 the invention: New analgesics with adjuvant anticancer properties.

Description of the invention:

Opiate analgesics like morphine or fentanyl are the most widely used medicines for relieving severe acute or chronic pain, including cancer pain. Unfortunately, chronic pain treatment is associated with fast development tolerance that creates needs of increase the doses. In addition, in the case of cancer opiates may stimulate progression of disease. Therefore peptide analogues as a new type of effective analgesic especially designed for chronic cancer pain treatment has been development. The compound is characterized with very high agonist affinities to MOR and also high, but ten times lower affinity to DOR. Affinity to hNK1 as an antagonist is also very significant. New compounds expressed antiproliferative properties on various cancer cells. Therefore, the compound should be considered as new analgesic for treatment cancer related pains with adjuvant anticancer properties which may support cancer treatments.

This invention has a potential for broad international application. The inventors are interested in commercialization of the invention and are seeking appropriate interested manufacturer.

EPO Patent Registration Services and Consulting GmbH has made direct contact with the inventors and has access to information about the invention directly from the inventors. Interested parties for the invention can contact EPO Patent Registration at